evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract
2129,GENE_BACKGROUND,,"CREBBP (CREB binding protein) is a transcriptional co-activator with intrinsic histone acetyltransferase (HAT) activity; it is closely homologous to the co-activator EP300 (PMID: 8004670, 18273021). As a co-factor, CREBBP binds to DNA binding proteins where it functions as a scaffold to recruit a range of transcription complex components (PMID: 9215639, 9445474). CREBBP itself can recruit the basal transcriptional machinery, and through its HAT activity acetylate lysine tails to modify chromatin into a more open conformation for active transcription (PMID: 8576192,8967953). The HAT activity of CREBBP is also active on non-histone proteins, including tumor suppressors such as p53 and tissue-specific transcription factors such as GATA1 (PMID: 9830059, 9859997). In leukemias, CREBBP can be disrupted by translocations that fuse the HAT domain with the MOZ/KAT6A (lysine acetyltransferase 6a) protein t(8;16) (PMID: 9447825). Somatic mutations of CREBBP have been found in leukemia, lymphoma and solid tumors including small-cell lung cancer, squamous carcinoma and bladder cancer (PMID: 24670651, 21796119, 21390130, 25151357, 21390130). Most CREBBP mutations are truncating and commonly co-occur with loss of the wildtype allele, suggesting that CREBBP is a tumor suppressor. Inherited mutations can result in the Rubinstein-Taybi syndrome with stereotypical facial and digit abnormalities along with neurological deficits (PMID:7630403). CREBBP-mutated tumors are dependent on EP300 activity and inhibitors targeting EP300 are efficacious in CREBBP-mutated cell line and mouse models (PMID: 26603525).",,2017-09-01,,1387,CREBBP,CREB binding protein,False,ENST00000262367,NM_004380.2,CBP,KAT3A,RSTS,True,9859997,Regulation of activity of the transcription factor GATA-1 by acetylation.,Nature,0001-12-10,396,6711,594-8,Boyes J et al,,,0001-12-10,,7630403,Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.,Nature,0001-07-27,376,6538,348-51,Petrij F et al,,,0001-07-27,,9215639,Recruitment of p300/CBP in p53-dependent signal pathways.,Cell,0001-06-27,89,7,1175-84,Avantaggiati ML et al,,,0001-06-27,,21390130,CREBBP mutations in relapsed acute lymphoblastic leukaemia.,Nature,2018-03-10T20:11:00,471,7337,235-9,Mullighan CG et al,doi: 10.1038/nature09727,,0001-03-10,,26603525,Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.,Cancer discovery,2018-04-01T20:16:00,6,4,430-45,Ogiwara H et al,doi: 10.1158/2159-8290.CD-15-0754,,0001-04-01,,24670651,Identification of genomic alterations in oesophageal squamous cell cancer.,Nature,2018-05-01T20:14:00,509,7498,1991-05-01,Song Y et al,doi: 10.1038/nature13176,,0001-05-01,,18273021,The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.,Nature,2018-02-14T20:08:00,451,7180,846-50,Liu X et al,doi: 10.1038/nature06546,,0001-02-14,,9830059,Phosphorylation of p53 serine 15 increases interaction with CBP.,The Journal of biological chemistry,0001-12-04,273,49,33048-53,Lambert PF et al,,,0001-12-04,,21796119,Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.,Nature,2018-07-27T20:11:00,476,7360,298-303,Morin RD et al,doi: 10.1038/nature10351,,2018-07-27T03:03:00,,9445474,Differential use of CREB binding protein-coactivator complexes.,"Science (New York, N.Y.)",0001-01-30,279,5351,700-3,Kurokawa R et al,,,0001-01-30,,8967953,The CBP co-activator is a histone acetyltransferase.,Nature,0001-12-19,384,6610,641-3,Bannister AJ et al,,,0001-12-19,,25151357,Genetic landscape of esophageal squamous cell carcinoma.,Nature genetics,2018-10-01T20:14:00,46,10,1097-102,Gao YB et al,doi: 10.1038/ng.3076,,2018-10-01T01:02:00,,9447825,Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).,Leukemia,0001-12-01,11,12,2087-96,Giles RH et al,,,0001-12-01,,8004670,E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators.,Cell,0001-06-17,77,6,799-800,Arany Z et al,,,2018-06-17T08:00:00,,8576192,Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator.,The Journal of biological chemistry,0001-02-02,271,5,2373-5,Kee BL et al,,,0001-02-02,
2128,GENE_SUMMARY,,CREBBP encodes a transcriptional co-activator with intrinsic histone acetyltransferase activity. Inherited mutations can result in the Rubinstein-Taybi syndrome.,,2017-04-03,,1387,CREBBP,CREB binding protein,False,ENST00000262367,NM_004380.2,CBP,KAT3A,RSTS,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
